Implication of the Purinergic System in Alcohol Use Disorders

Alcoholism: Clinical and Experimental Research

Volumn 35, Issue 4, 2011, Pages 584-594

  Asatryan, Liana ^a   Nam, Hyung W ^d   Lee, Moonnoh R ^d   Thakkar, Mahesh M ^b   Saeed Dar, M ^c   Davies, Daryl L ^a   Choi, Doo Sup ^d  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b University of Missouri   (United States)

^c EAST CAROLINA UNIVERSITY   (United States)

^d MAYO GRADUATE SCHOOL   (United States)

Author keywords

Adenosine; Alcoholism; ATP; Neurotransmission; Purinergic; Signaling

Indexed keywords

2 [4 (2 CARBOXYETHYL)PHENETHYLAMINO]ADENOSINE 5' (N ETHYLCARBOXAMIDE); 4 AMINOBUTYRIC ACID; 4 AMINOBUTYRIC ACID A RECEPTOR BLOCKING AGENT; 4 AMINOBUTYRIC ACID A RECEPTOR STIMULATING AGENT; 8 CYCLOPENTYL 1,3 DIPROPYLXANTHINE; ADENOSINE; ADENOSINE 5' (N ETHYLCARBOXAMIDE); ADENOSINE A1 RECEPTOR; ADENOSINE A1 RECEPTOR ANTAGONIST; ADENOSINE A2A RECEPTOR; ADENOSINE RECEPTOR STIMULATING AGENT; ADENOSINE TRIPHOSPHATE; ALCOHOL; BICUCULLINE; CYCLIC AMP; CYCLOHEXYLADENOSINE; DOPAMINE; G PROTEIN COUPLED RECEPTOR; GLUTAMIC ACID; METABOTROPIC RECEPTOR; MUSCIMOL; NEUROTRANSMITTER; NUCLEOSIDE TRANSPORTER; PURINERGIC P2X RECEPTOR; PURINERGIC P2Y RECEPTOR; RECEPTOR SUBUNIT;

ALCOHOL USE DISORDER; ALCOHOLISM; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ASTROCYTE; ATAXIA; BRAIN; CENTRAL NERVOUS SYSTEM; DOPAMINERGIC SYSTEM; DRUG MEGADOSE; GLIA CELL; HYPNOSIS; MOUSE; NERVE CELL; NEUROTRANSMISSION; NONHUMAN; PRIORITY JOURNAL; RAT; SEDATION; SIGNAL TRANSDUCTION; SLEEP WAKING CYCLE; VENTRAL TEGMENTUM;

ADENOSINE; ADENOSINE TRIPHOSPHATE; ALCOHOL-RELATED DISORDERS; ANIMALS; CEREBRAL CORTEX; EQUILIBRATIVE NUCLEOSIDE TRANSPORTER 1; ETHANOL; GLUTAMIC ACID; HUMANS; NUCLEOSIDE TRANSPORT PROTEINS; SYNAPTIC TRANSMISSION;

EID: 79952191146     PISSN: 01456008     EISSN: 15300277     Source Type: Journal    
DOI: 10.1111/j.1530-0277.2010.01379.x     Document Type: Article

References (161)

1. Acquaah-Mensah GK, Misra V, Biswal S (2006) Ethanol sensitivity: a central role for CREB transcription regulation in the cerebellum. BMC Genomics 7:308.
2. Adams CL, Cowen MS, Short JL, Lawrence AJ (2008) Combined antagonism of glutamate mGlu5 and adenosine A2A receptors interact to regulate alcohol-seeking in rats. Int J Neuropsychopharmacol 11:229-241.
3. Alam MN, Szymusiak R, Gong H, King J, McGinty D (1999) Adenosinergic modulation of rat basal forebrain neurons during sleep and waking: neuronal recording with microdialysis. J Physiol 521:679-690.
4. Al-Rejaie S, Dar MS (2006a) Behavioral interaction between nicotine and ethanol: possible modulation by mouse cerebellar glutamate. Alcohol Clin Exp Res 30:1223-1233.
5. Al-Rejaie S, Dar MS (2006b) Possible role of mouse cerebellar nitric oxide in the behavioral interaction between chronic intracerebellar nicotine and acute ethanol administration: observation of cross-tolerance. Neuroscience 138:575-585.
6. Anderson CM, Baldwin SA, Young JD, Cass CE, Parkinson FE (1999a) Distribution of mRNA encoding a nitrobenzylthioinosine-insensitive nucleoside transporter (ENT2) in rat brain. Brain Res Mol Brain Res 70:293-297.
7. Anderson CM, Xiong W, Geiger JD, Young JD, Cass CE, Baldwin SA, Parkinson FE (1999b) Distribution of equilibrative, nitrobenzylthioinosine-sensitive nucleoside transporters (ENT1) in brain. J Neurochem 73:867-873.
8. Anton RF, Oroszi G, O'Malley S, Couper D, Swift R, Pettinati H, Goldman D (2008) An evaluation of mu-opioid receptor (OPRM1) as a predictor of naltrexone response in the treatment of alcohol dependence: results from the Combined Pharmacotherapies and Behavioral Interventions for Alcohol Dependence (COMBINE) study. Arch Gen Psychiatry 65:135-144.
9. Arolfo MP, Yao L, Gordon AS, Diamond I, Janak PH (2004) Ethanol operant self-administration in rats is regulated by adenosine A2 receptors. Alcohol Clin Exp Res 28:1308-1316.
10. Arrigoni E, Chamberlin NL, Saper CB, McCarley RW (2006) Adenosine inhibits basal forebrain cholinergic and noncholinergic neurons in vitro. Neuroscience 140:403-413.
11. Asatryan L, Popova M, Perkins D, Trudell JR, Alkana RL, Davies DL (2010) Ivermectin antagonizes ethanol inhibition in P2x4 receptors. J Pharmacol Exp Ther 334:720-728.
12. Asatryan L, Popova M, Woodward JJ, King BF, Alkana RL, Davies DL (2008) Roles of ectodomain and transmembrane regions in ethanol and agonist action in purinergic P2X2 and P2X3 receptors. Neuropharmacology 55:835-843.
13. Aschrafi A, Sadtler S, Niculescu C, Rettinger J, Schmalzing G (2004) Trimeric architecture of homomeric P2X2 and heteromeric P2X1+2 receptor subtypes. J Mol Biol 342:333-343.
14. Baldwin SA, Mackey JR, Cass CE, Young JD (1999) Nucleoside transporters: molecular biology and implications for therapeutic development. Mol Med Today 5:216-224.
15. Bantel C, Childers SR, Eisenach JC (2002) Role of adenosine receptors in spinal G-protein activation after peripheral nerve injury. Anesthesiology 96:1443-1449.
16. Barwick VS, Dar MS (1998) Adenosinergic modulation of ethanol-induced motor incoordination in the rat motor cortex. Prog Neuropsychopharmacol Biol Psychiatry 22:587-607.
17. Basheer R, Strecker RE, Thakkar MM, McCarley RW (2004) Adenosine and sleep-wake regulation. Prog Neurobiol 73:379-396.
18. Basso AM, Bratcher NA, Harris RR, Jarvis MF, Decker MW, Rueter LE (2009) Behavioral profile of P2X7 receptor knockout mice in animal models of depression and anxiety: relevance for neuropsychiatric disorders. Behav Brain Res 198:83-90.
19. Batista LC, Prediger RD, Morato GS, Takahashi RN (2005) Blockade of adenosine and dopamine receptors inhibits the development of rapid tolerance to ethanol in mice. Psychopharmacology (Berl) 181:714-721.
20. Besheer J, Grondin JJ, Salling MC, Spanos M, Stevenson RA, Hodge CW (2009) Interoceptive effects of alcohol require mGlu5 receptor activity in the nucleus accumbens. J Neurosci 29:9582-9591.
21. Blanco-Centurion C, Xu M, Murillo-Rodriguez E, Gerashchenko D, Shiromani AM, Salin-Pascual RJ, Hof PR, Shiromani PJ (2006) Adenosine and sleep homeostasis in the Basal forebrain. J Neurosci 26:8092-8100.
22. Brower KJ (2001) Alcohol's effects on sleep in alcoholics. Alcohol Res Health 25:110-125.
23. Buell G, Lewis C, Collo G, North RA, Surprenant A (1996) An antagonist-insensitive P2X receptor expressed in epithelia and brain. EMBO J 15:55-62.
24. Burnstock G (1972) Purinergic nerves. Pharmacol Rev 24:509-581.
25. Burnstock G (2008) Purinergic signalling and disorders of the central nervous system. Nat Rev Drug Discov 7:575-590.
26. Carta M, Mameli M, Valenzuela CF (2004) Alcohol enhances GABAergic transmission to cerebellar granule cells via an increase in Golgi cell excitability. J Neurosci 24:3746-3751.
27. Chen J, Nam HW, Lee MR, Hinton DJ, Choi S, Kim T, Kawamura T, Janak PH, Choi D-S (2010) Altered glutamatergic neurotransmission in the striatum regulates ethanol sensitivity and intake in mice lacking ENT1. Behav Brain Res 208:636-642.
28. Choi DS, Cascini MG, Mailliard W, Young H, Paredes P, McMahon T, Diamond I, Bonci A, Messing RO (2004) The type 1 equilibrative nucleoside transporter regulates ethanol intoxication and preference. Nat Neurosci 7:855-861.
29. Ciruela F, Casado V, Rodrigues RJ, Lujan R, Burgueno J, Canals M, Borycz J, Rebola N, Goldberg SR, Mallol J, Cortes A, Canela EI, Lopez-Gimenez JF, Milligan G, Lluis C, Cunha RA, Ferre S, Franco R (2006) Presynaptic control of striatal glutamatergic neurotransmission by adenosine A1-A2A receptor heteromers. J Neurosci 26:2080-2087.
30. Clark M, Dar MS (1989a) Effect of acute ethanol on release of endogenous adenosine from rat cerebellar synaptosomes. J Neurochem 52:1859-1865.
31. Clark M, Dar MS (1989b) Effect of acute ethanol on uptake of [3H]adenosine by rat cerebellar synaptosomes. Alcohol Clin Exp Res 13:371-377.
32. Clark M, Dar MS (1989c) Release of endogenous glutamate from rat cerebellar synaptosomes: interactions with adenosine and ethanol. Life Sci 44:1625-1635.
33. Clark M, Weiss SR, Post RM (1993) Autoradiographic analysis of serotonin receptors and transporter in kindled rat brain. Neurosci Lett 161:21-26.
34. Concas A, Mascia MP, Cuccheddu T, Floris S, Mostallino MC, Perra C, Satta S, Biggio G (1996) Chronic ethanol intoxication enhances [3H]CCPA binding and does not reduce A1 adenosine receptor function in rat cerebellum. Pharmacol Biochem Behav 53:249-255.
35. Crawford CR, Patel DH, Naeve C, Belt JA (1998) Cloning of the human equilibrative, nitrobenzylmercaptopurine riboside (NBMPR)-insensitive nucleoside transporter ei by functional expression in a transport-deficient cell line. J Biol Chem 273:5288-5293.
36. Cully DF, Vassilatis DK, Liu KK, Paress PS, Van der Ploeg LH, Schaeffer JM, Arena JP (1994) Cloning of an avermectin-sensitive glutamate-gated chloride channel from Caenorhabditis elegans. Nature 371:707-711.
37. Dar MS (1990) Central adenosinergic system involvement in ethanol-induced motor incoordination in mice. J Pharmacol Exp Ther 255:1202-1209.
38. Dar MS (1997) Mouse cerebellar adenosinergic modulation of ethanol-induced motor incoordination: possible involvement of cAMP. Brain Res 749:263-274.
39. Dar MS (1998) Involvement of kappa-opioids in the mouse cerebellar adenosinergic modulation of ethanol-induced motor incoordination. Alcohol Clin Exp Res 22:444-454.
40. Dar MS (2001) Modulation of ethanol-induced motor incoordination by mouse striatal A(1) adenosinergic receptor. Brain Res Bull 55:513-520.
41. Dar MS (2006) Co-modulation of acute ethanol-induced motor impairment by mouse cerebellar adenosinergic A1 and GABA(A) receptor systems. Brain Res Bull 71:287-295.
42. Dar MS, Mustafa SJ (2002) Acute ethanol/cannabinoid-induced ataxia and its antagonism by oral/systemic/intracerebellar A1 adenosine receptor antisense in mice. Brain Res 957:53-60.
43. Dar MS, Mustafa SJ, Wooles WR (1983) Possible role of adenosine in the CNS effects of ethanol. Life Sci 33:1363-1374.
44. Davies DL, Kochegarov AA, Kuo ST, Kulkarni AA, Woodward JJ, King BF, Alkana RL (2005) Ethanol differentially affects ATP-gated P2X(3) and P2X(4) receptor subtypes expressed in Xenopus oocytes. Neuropharmacology 49:243-253.
45. Davies DL, Machu TK, Guo Y, Alkana RL (2002) Ethanol sensitivity in ATP-gated P2X receptors is subunit dependent. Alcohol Clin Exp Res 26:773-778.
46. Dawson GR, Wafford KA, Smith A, Marshall GR, Bayley PJ, Schaeffer JM, Meinke PT, McKernan RM (2000) Anticonvulsant and adverse effects of avermectin analogs in mice are mediated through the gamma-aminobutyric acid(A) receptor. J Pharmacol Exp Ther 295:1051-1060.
47. Dent JA, Davis MW, Avery L (1997) avr-15 encodes a chloride channel subunit that mediates inhibitory glutamatergic neurotransmission and ivermectin sensitivity in Caenorhabditis elegans. EMBO J 16:5867-5879.
48. Diamond I, Gordon AS (1994) The role of adenosine in mediating cellular and molecular responses to ethanol, in Toward a Molecular Basis of Alcohol Use and Abuse (Jansson B, Jörnvall H, Rydberg U, Terenius L, Vallee BL eds), pp. 175-183. Birkhäuser Verlag, Basel.
49. Diaz-Cabiale Z, Vivo M, Del Arco A, O'Connor WT, Harte MK, Muller CE, Martinez E, Popoli P, Fuxe K, Ferre S (2002) Metabotropic glutamate mGlu5 receptor-mediated modulation of the ventral striopallidal GABA pathway in rats. Interactions with adenosine A(2A) and dopamine D(2) receptors. Neurosci Lett 324:154-158.
50. Dunwiddie TV, Masino SA (2001) The role and regulation of adenosine in the central nervous system. Annu Rev Neurosci 24:31-55.
51. El Yacoubi M, Ledent C, Parmentier M, Bertorelli R, Ongini E, Costentin J, Vaugeois JM (2001) Adenosine A2A receptor antagonists are potential antidepressants: evidence based on pharmacology and A2A receptor knockout mice. Br J Pharmacol 134:68-77.
52. Fedele E, Varnier G, Ansaldo MA, Raiteri M (1998) Nicotine administration stimulates the in vivo N-methyl-D-aspartate receptor/nitric oxide/cyclic GMP pathway in rat hippocampus through glutamate release. Br J Pharmacol 125:1042-1048.
53. Ferre S, Ciruela F, Borycz J, Solinas M, Quarta D, Antoniou K, Quiroz C, Justinova Z, Lluis C, Franco R, Goldberg SR (2008) Adenosine A1-A2A receptor heteromers: new targets for caffeine in the brain. Front Biosci 13:2391-2399.
54. Ferre S, Fredholm BB, Morelli M, Popoli P, Fuxe K (1997) Adenosine-dopamine receptor-receptor interactions as an integrative mechanism in the basal ganglia. Trends Neurosci 20:482-487.
55. Ferre S, Karcz-Kubicha M, Hope BT, Popoli P, Burgueno J, Gutierrez MA, Casado V, Fuxe K, Goldberg SR, Lluis C, Franco R, Ciruela F (2002) Synergistic interaction between adenosine A2A and glutamate mGlu5 receptors: implications for striatal neuronal function. Proc Natl Acad Sci U S A 99:11940-11945.
56. Ferre S, Popoli P, Tinner-Staines B, Fuxe K (1996) Adenosine A1 receptor-dopamine D1 receptor interaction in the rat limbic system: modulation of dopamine D1 receptor antagonist binding sites. Neurosci Lett 208:109-112.
57. Ferre S, Schwarcz R, Li XM, Snaprud P, Ogren SO, Fuxe K (1994) Chronic haloperidol treatment leads to an increase in the intramembrane interaction between adenosine A2 and dopamine D2 receptors in the neostriatum. Psychopharmacology (Berl) 116:279-284.
58. 2 receptors in rat striatal membranes. Proc Natl Acad Sci U S A 88:7238-7241.
59. Fredholm BB (2010) Adenosine receptors as drug targets. Exp Cell Res 316:1284-1288.
60. Fredholm BB, Chen JF, Masino SA, Vaugeois JM (2005) Actions of adenosine at its receptors in the CNS: insights from knockouts and drugs. Annu Rev Pharmacol Toxicol 45:385-412.
61. Geary TG (2005) Ivermectin 20years on: maturation of a wonder drug. Trends Parasitol 21:530-532.
62. Gonzales RA, Job MO, Doyon WM (2004) The role of mesolimbic dopamine in the development and maintenance of ethanol reinforcement. Pharmacol Ther 103:121-146.
63. Gordon AS, Collier K, Diamond I (1986) Ethanol regulation of adenosine receptor-stimulated cAMP levels in a clonal neural cell line: an in vitro model of cellular tolerance to ethanol. Proc Natl Acad Sci U S A 83:2105-2108.
64. Greengard P (2001) The neurobiology of slow synaptic transmission. Science 294:1024-1030.
65. Greengard P, Allen PB, Nairn AC (1999) Beyond the dopamine receptor: the DARPP-32/protein phosphatase-1 cascade. Neuron 23:435-447.
66. Griffiths M, Beaumont N, Yao SY, Sundaram M, Boumah CE, Davies A, Kwong FY, Coe I, Cass CE, Young JD, Baldwin SA (1997a) Cloning of a human nucleoside transporter implicated in the cellular uptake of adenosine and chemotherapeutic drugs [see comments]. Nat Med 3:89-93.
67. Griffiths M, Yao SY, Abidi F, Phillips SE, Cass CE, Young JD, Baldwin SA (1997b) Molecular cloning and characterization of a nitrobenzylthioinosine-insensitive (ei) equilibrative nucleoside transporter from human placenta. Biochem J 328:739-743.
68. Hack SP, Christie MJ (2003) Adaptations in adenosine signaling in drug dependence: therapeutic implications. Crit Rev Neurobiol 15:235-274.
69. Harvey J, Lacey MG (1997) A postsynaptic interaction between dopamine D1 and NMDA receptors promotes presynaptic inhibition in the rat nucleus accumbens via adenosine release. J Neurosci 17:5271-5280.
70. Heine C, Wegner A, Grosche J, Allgaier C, Illes P, Franke H (2007) P2 receptor expression in the dopaminergic system of the rat brain during development. Neuroscience 149:165-181.
71. Herz A (1997) Endogenous opioid systems and alcohol addiction. Psychopharmacology 129:99-111.
72. Hodge CW, Miles MF, Sharko AC, Stevenson RA, Hillmann JR, Lepoutre V, Besheer J, Schroeder JP (2006) The mGluR5 antagonist MPEP selectively inhibits the onset and maintenance of ethanol self-administration in C57BL/6J mice. Psychopharmacology (Berl) 183:429-438.
73. Honore P, Donnelly-Roberts D, Namovic MT, Hsieh G, Zhu CZ, Mikusa JP, Hernandez G, Zhong C, Gauvin DM, Chandran P, Harris R, Medrano AP, Carroll W, Marsh K, Sullivan JP, Faltynek CR, Jarvis MF (2006) A-740003 [N-(1-{[(cyanoimino)(5-quinolinylamino) methyl]amino}-2, 2-dimethylpropyl)-2-(3, 4-dimethoxyphenyl)acetamide], a novel and selective P2X7 receptor antagonist, dose-dependently reduces neuropathic pain in the rat. J Pharmacol Exp Ther 319:1376-1385.
74. Hyde RJ, Cass CE, Young JD, Baldwin SA (2001) The ENT family of eukaryote nucleoside and nucleobase transporters: recent advances in the investigation of structure/function relationships and the identification of novel isoforms. Mol Membr Biol 18:53-63.
75. Inoue K (2008) Purinergic systems in microglia. Cell Mol Life Sci 65:3074-3080.
76. Jarvis MF, Becker HC (1998) Single and repeated episodes of ethanol withdrawal increase adenosine A1, but not A2A, receptor density in mouse brain. Brain Res 786:80-88.
77. Jarvis MF, Burgard EC, McGaraughty S, Honore P, Lynch K, Brennan TJ, Subieta A, Van Biesen T, Cartmell J, Bianchi B, Niforatos W, Kage K, Yu H, Mikusa J, Wismer CT, Zhu CZ, Chu K, Lee CH, Stewart AO, Polakowski J, Cox BF, Kowaluk E, Williams M, Sullivan J, Faltynek C (2002) A-317491, a novel potent and selective non-nucleotide antagonist of P2X3 and P2X2/3 receptors, reduces chronic inflammatory and neuropathic pain in the rat. Proc Natl Acad Sci U S A 99:17179-17184.
78. Jelinkova I, Vavra V, Jindrichova M, Obsil T, Zemkova HW, Zemkova H, Stojilkovic SS (2008) Identification of P2X(4) receptor transmembrane residues contributing to channel gating and interaction with ivermectin. Pflugers Arch 456:939-950.
79. Jelinkova I, Yan Z, Liang Z, Moonat S, Teisinger J, Stojilkovic SS, Zemkova H (2006) Identification of P2X4 receptor-specific residues contributing to the ivermectin effects on channel deactivation. Biochem Biophys Res Commun 349:619-625.
80. Jennings LI, Hao C, Cabrita MA, Vickers MF, Baldwin SA, Young JD, Cass CE (2001) Distinct regional distribution of human equilibrative nucleoside transporter proteins 1 and 2 (hENT1 and hENT2) in the central nervous system. Neuropharmacology 10:722-731.
81. Jiang LH, Kim M, Spelta V, Bo X, Surprenant A, North RA (2003) Subunit arrangement in P2X receptors. J Neurosci 23:8903-8910.
82. Kachroo A, Orlando LR, Grandy DK, Chen JF, Young AB, Schwarzschild MA (2005) Interactions between metabotropic glutamate 5 and adenosine A2A receptors in normal and parkinsonian mice. J Neurosci 25:10414-10419.
83. Kalinchuk AV, McCarley RW, Stenberg D, Porkka-Heiskanen T, Basheer R (2008) The role of cholinergic basal forebrain neurons in adenosine-mediated homeostatic control of sleep: lessons from 192 IgG-saporin lesions. Neuroscience 157:238-253.
84. Kalivas PW (2009) The glutamate homeostasis hypothesis of addiction. Nat Rev Neurosci 10:561-572.
85. Kaplan GB, Bharmal NH, Leite-Morris KA, Adams WR (1999) Role of adenosine A1 and A2A receptors in the alcohol withdrawal syndrome. Alcohol 19:157-162.
86. Kaur S, Junek A, Black MA, Semba K (2008) Effects of ibotenate and 192IgG-saporin lesions of the nucleus basalis magnocellularis/substantia innominata on spontaneous sleep and wake states and on recovery sleep after sleep deprivation in rats. J Neurosci 28:491-504.
87. Kawate T, Michel JC, Birdsong WT, Gouaux E (2009) Crystal structure of the ATP-gated P2X(4) ion channel in the closed state. Nature 460:592-598.
88. Khakh BS, Burnstock G, Kennedy C, King BF, North RA, Seguela P, Voigt M, Humphrey PP (2001) International union of pharmacology. XXIV. Current status of the nomenclature and properties of P2X receptors and their subunits. Pharmacol Rev 53:107-118.
89. Khakh BS, Proctor WR, Dunwiddie TV, Labarca C, Lester HA (1999) Allosteric control of gating and kinetics at P2X(4) receptor channels. J Neurosci 19:7289-7299.
90. Krause RM, Buisson B, Bertrand S, Corringer PJ, Galzi JL, Changeux JP, Bertrand D (1998) Ivermectin: a positive allosteric effector of the alpha7 neuronal nicotinic acetylcholine receptor. Mol Pharmacol 53:283-294.
91. Krauss SW, Ghirnikar RB, Diamond I, Gordon AS (1993) Inhibition of adenosine uptake by ethanol is specific for one class of nucleoside transporters. Mol Pharmacol 44:1021-1026.
92. Labrousse VF, Costes L, Aubert A, Darnaudery M, Ferreira G, Amedee T, Laye S (2009) Impaired interleukin-1beta and c-Fos expression in the hippocampus is associated with a spatial memory deficit in P2X(7) receptor-deficient mice. PLoS ONE 4:e6006.
93. Lalo U, Pankratov Y, Wichert SP, Rossner MJ, North RA, Kirchhoff F, Verkhratsky A (2008) P2X1 and P2X5 subunits form the functional P2X receptor in mouse cortical astrocytes. J Neurosci 28:5473-5480.
94. Le KT, Babinski K, Seguela P (1998) Central P2X4 and P2X6 channel subunits coassemble into a novel heteromeric ATP receptor. J Neurosci 18:7152-7159.
95. 3 receptor subunits can account for ATP-gated curents in sensory neurons. Nature 377:432-435.
96. Lonze BE, Ginty DD (2002) Function and regulation of CREB family transcription factors in the nervous system. Neuron 35:605-623.
97. Mailliard WS, Diamond I (2004) Recent advances in the neurobiology of alcoholism: the role of adenosine. Pharmacol Ther 101:39-46.
98. Manzoni OJ, Manabe T, Nicoll RA (1994) Release of adenosine by activation of NMDA receptors in the hippocampus. Science 265:2098-2101.
99. Marcoli M, Maura G, Cervetto C, Giacomini C, Oliveri D, Candiani S, Pestarino M (2006) Nitric oxide-evoked cGMP production in Purkinje cells in rat cerebellum: an immunocytochemical and pharmacological study. Neurochem Int 49:683-690.
100. McCarley RW (2007) Neurobiology of REM and NREM sleep. Sleep Med 8:302-330.
101. Mendelson WB (2001) The sleep-inducing effect of ethanol microinjection into the medial preoptic area is blocked by flumazenil. Brain Res 892:118-121.
102. Meng ZH, Anwer J, Dar MS (1997) The striatal adenosinergic modulation of ethanol-induced motor incoordination in rats: possible role of chloride flux. Brain Res 776:235-245.
103. Murillo-Rodriguez E, Blanco-Centurion C, Gerashchenko D, Salin-Pascual RJ, Shiromani PJ (2004) The diurnal rhythm of adenosine levels in the basal forebrain of young and old rats. Neuroscience 123:361-370.
104. Naassila M, Ledent C, Daoust M (2002) Low ethanol sensitivity and increased ethanol consumption in mice lacking adenosine A2A receptors. J Neurosci 22:10487-10493.
105. Nagy LE, Diamond I, Casso DJ, Franklin C, Gordon AS (1990) Ethanol increases extracellular adenosine by inhibiting adenosine uptake via the nucleoside transporter. J Biol Chem 265:1946-1951.
106. Nagy LE, Diamond I, Collier K, Lopez L, Ullman B, Gordon AS (1989) Adenosine is required for ethanol-induced heterologous desensitization. Mol Pharmacol 36:744-748.
107. Nam HW, Lee MR, Hinton DJ, Choi DS (2010) Reduced effect of NMDA glutamate receptor antagonist on ethanol-induced ataxia and striatal glutamate levels in mice lacking ENT1. Neurosci Lett 479:277-281.
108. Nestler EJ (2001) Molecular basis of long-term plasticity underlying addiction. Nat Rev Neurosci 2:119-128.
109. Newton PM, Messing RO (2006) Intracellular signaling pathways that regulate behavioral responses to ethanol. Pharmacol Ther 109:227-237.
110. Nicke A, Kerschensteiner D, Soto F (2005) Biochemical and functional evidence for heteromeric assembly of P2X1 and P2X4 subunits. J Neurochem 92:925-933.
111. Nishi A, Liu F, Matsuyama S, Hamada M, Higashi H, Nairn AC, Greengard P (2003) Metabotropic mGlu5 receptors regulate adenosine A2A receptor signaling. Proc Natl Acad Sci U S A 100:1322-1327.
112. North RA (2002) Molecular physiology of P2X receptors. Physiol Rev 82:1013-1067.
113. Offenhauser N, Castelletti D, Mapelli L, Soppo BE, Regondi MC, Rossi P, D'Angelo E, Frassoni C, Amadeo A, Tocchetti A, Pozzi B, Disanza A, Guarnieri D, Betsholtz C, Scita G, Heberlein U, Di Fiore PP (2006) Increased ethanol resistance and consumption in Eps8 knockout mice correlates with altered actin dynamics. Cell 127:213-226.
114. Olive MF, McGeehan AJ, Kinder JR, McMahon T, Hodge CW, Janak PH, Messing RO (2005) The mGluR5 antagonist 6-methyl-2-(phenylethynyl)pyridine decreases ethanol consumption via a protein kinase C epsilon-dependent mechanism. Mol Pharmacol 67:349-355.
115. Omura S (2008) Ivermectin: 25years and still going strong. Int J Antimicrob Agents 31:91-98.
116. Pandey SC, Roy A, Zhang H, Xu T (2004) Partial deletion of the cAMP response element-binding protein gene promotes alcohol-drinking behaviors. J Neurosci 24:5022-5030.
117. Parkinson FE, Xiong W, Zamzow CR, Chestley T, Mizuno T, Duckworth ML (2009) Transgenic expression of human equilibrative nucleoside transporter 1 in mouse neurons. J Neurochem 109:562-572.
118. 1 receptor antisense oligodeoxynucleotide blocks ethanol-induced motor incoordination. Eur J Pharmacol 323:R5-R7.
119. Popova M, Asatryan L, Ostrovskaya O, Wyatt LR, Li K, Alkana RL, Davies DL (2010) A point mutation in the ectodomain-transmembrane 2 interface eliminates the inhibitory effects of ethanol in P2X4 receptors. J Neurochem 112:307-317.
120. Porkka-Heiskanen T, Strecker RE, Thakkar M, Bjorkum AA, Greene RW, McCarley RW (1997) Adenosine: a mediator of the sleep-inducing effects of prolonged wakefulness. Science 276:1265-1268.
121. Portas CM, Thakkar M, Rainnie DG, Greene RW, McCarley RW (1997) Role of adenosine in behavioral state modulation: a microdialysis study in the freely moving cat. Neuroscience 79:225-235.
122. Prediger RD, da Silva GE, Batista LC, Bittencourt AL, Takahashi RN (2006) Activation of Adenosine A(1) Receptors Reduces Anxiety-Like Behavior During Acute Ethanol Withdrawal (Hangover) in Mice. Neuropsychopharmacology 31:2210-2220.
123. Proctor WR, Dunwiddie TV (1984) Behavioral sensitivity to purinergic drugs parallels ethanol sensitivity in selectively bred mice. Science 224:519-521.
124. Quarta D, Borycz J, Solinas M, Patkar K, Hockemeyer J, Ciruela F, Lluis C, Franco R, Woods AS, Goldberg SR, Ferre S (2004a) Adenosine receptor-mediated modulation of dopamine release in the nucleus accumbens depends on glutamate neurotransmission and N-methyl-D-aspartate receptor stimulation. J Neurochem 91:873-880.
125. Quarta D, Ferre S, Solinas M, You ZB, Hockemeyer J, Popoli P, Goldberg SR (2004b) Opposite modulatory roles for adenosine A1 and A2A receptors on glutamate and dopamine release in the shell of the nucleus accumbens. Effects of chronic caffeine exposure. J Neurochem 88:1151-1158.
126. Radulovacki M, Virus RM, Djuricic-Nedelson M, Green RD (1984) Adenosine analogs and sleep in rats. J Pharmacol Exp Ther 228:268-274.
127. Richard-Lenoble D, Chandenier J, Gaxotte P (2003) Ivermectin and filariasis. Fundam Clin Pharmacol 17:199-203.
128. Risinger FO, Freeman PA, Greengard P, Fienberg AA (2001) Motivational effects of ethanol in DARPP-32 knock-out mice. J Neurosci 21:340-348.
129. Roehrs T, Roth T (2001) Sleep, sleepiness, and alcohol use. Alcohol Res Health 25:101-109.
130. Sattelle DB, Buckingham SD, Akamatsu M, Matsuda K, Pienaar IS, Jones AK, Sattelle BM, Almond A, Blundell CD (2009) Comparative pharmacology and computational modelling yield insights into allosteric modulation of human alpha7 nicotinic acetylcholine receptors. Biochem Pharmacol 78:836-843.
131. Sawynok J, Liu XJ (2003) Adenosine in the spinal cord and periphery: release and regulation of pain. Prog Neurobiol 69:313-340.
132. Shan Q, Haddrill JL, Lynch JW (2001) Ivermectin, an unconventional agonist of the glycine receptor chloride channel. J Biol Chem 276:12556-12564.
133. Short JL, Drago J, Lawrence AJ (2006b) Comparison of ethanol preference and neurochemical measures of mesolimbic dopamine and adenosine systems across different strains of mice. Alcohol Clin Exp Res 30:606-620.
134. Short JL, Ledent C, Borrelli E, Drago J, Lawrence AJ (2006a) Genetic interdependence of adenosine and dopamine receptors: evidence from receptor knockout mice. Neuroscience 139:661-670.
135. Silberberg SD, Li M, Swartz KJ (2007) Ivermectin Interaction with transmembrane helices reveals widespread rearrangements during opening of P2X receptor channels. Neuron 54:263-274.
136. Sim JA, Chaumont S, Jo J, Ulmann L, Young MT, Cho K, Buell G, North RA, Rassendren F (2006) Altered hippocampal synaptic potentiation in P2X4 knock-out mice. J Neurosci 26:9006-9009.
137. Soto F, Garcia-Guzman M, Karschin C, Stuhmer W (1996) Cloning and tissue distribution of a novel P2X receptor from rat brain. Biochem Biophys Res Commun 223:456-460.
138. Spanagel R, Kiefer F (2008) Drugs for relapse prevention of alcoholism: ten years of progress. Trends Pharmacol Sci 29:109-115.
139. Spanagel R, Pendyala G, Abarca C, Zghoul T, Sanchis-Segura C, Magnone MC, Lascorz J, Depner M, Holzberg D, Soyka M, Schreiber S, Matsuda F, Lathrop M, Schumann G, Albrecht U (2005) The clock gene Per2 influences the glutamatergic system and modulates alcohol consumption. Nat Med 11:35-42.
140. Spanagel R, Weiss F (1999) The dopamine hypothesis of reward: past and current status. Trends Neurosci 22:521-527.
141. Stojilkovic SS (2009) Purinergic regulation of hypothalamopituitary functions. Trends Endocrinol Metab 20:460-468.
142. Surprenant A, North RA (2009) Signaling at purinergic P2X receptors. Annu Rev Physiol 71:333-359.
143. Tabakoff B, Saba L, Printz M, Flodman P, Hodgkinson C, Goldman D, Koob G, Richardson HN, Kechris K, Bell RL, Hubner N, Heinig M, Pravenec M, Mangion J, Legault L, Dongier M, Conigrave KM, Whitfield JB, Saunders J, Grant B, Hoffman PL (2009) Genetical genomic determinants of alcohol consumption in rats and humans. BMC Biol 7:70.
144. Thakkar MM, Delgiacco RA, Strecker RE, McCarley RW (2003a) Adenosinergic inhibition of basal forebrain wakefulness-active neurons: a simultaneous unit recording and microdialysis study in freely behaving cats. Neuroscience 122:1107-1113.
145. Thakkar MM, Engemann SC, Sharma R, Sahota P (2010) Role of wake-promoting basal forebrain and adenosinergic mechanisms in sleep-promoting effects of ethanol. Alcohol Clin Exp Res 34:997-1005.
146. Thakkar M, Mallick BN (1996) Effect of rapid eye movement sleep deprivation on 5'-nucleotidase activity in the rat brain. Neurosci Lett 206:177-180.
147. Thakkar MM, Winston S, McCarley RW (2003b) A1 receptor and adenosinergic homeostatic regulation of sleep-wakefulness: effects of antisense to the A1 receptor in the cholinergic basal forebrain. J Neurosci 23:4278-4287.
148. Thorsell A, Johnson J, Heilig M (2007) Effect of the adenosine A2a receptor antagonist 3, 7-dimethyl-propargylxanthine on anxiety-like and depression-like behavior and alcohol consumption in Wistar Rats. Alcohol Clin Exp Res 31:1302-1307.
149. Trang T, Beggs S, Salter MW (2006) Purinoceptors in microglia and neuropathic pain. Pflugers Arch 452:645-652.
150. Tsuda M, Kuboyama K, Inoue T, Nagata K, Tozaki-Saitoh H, Inoue K (2009) Behavioral phenotypes of mice lacking purinergic P2X4 receptors in acute and chronic pain assays. Mol Pain 5:28.
151. Ulmann L, Hatcher JP, Hughes JP, Chaumont S, Green PJ, Conquet F, Buell GN, Reeve AJ, Chessell IP, Rassendren F (2008) Up-regulation of P2X4 receptors in spinal microglia after peripheral nerve injury mediates BDNF release and neuropathic pain. J Neurosci 28:11263-11268.
152. Voogd J, Glickstein M (1998) The anatomy of the cerebellum. Trends Neurosci 21:370-375.
153. Wang Y, Haughey NJ, Mattson MP, Furukawa K (2004) Dual effects of ATP on rat hippocampal synaptic plasticity. Neuroreport 15:633-636.
154. Wu J, Lee MR, Choi S, Kim T, Choi D-S (2010) ENT1 regulates ethanol-sensitive EAAT2 expression and function in astrocytes. Alcohol Clin Exp Res 34:1110-1117.
155. Xiao C, Zhou C, Li K, Davies DL, Ye JH (2008) Purinergic type 2 receptors at GABAergic synapses on ventral tegmental area dopamine neurons are targets for ethanol action. J Pharmacol Exp Ther 327:196-205.
156. Xiong K, Li C, Weight FF (2000) Inhibition by ethanol of rat P2X(4) receptors expressed in Xenopus oocytes. Br J Pharmacol 130:1394-1398.
157. Yamamoto K, Sokabe T, Matsumoto T, Yoshimura K, Shibata M, Ohura N, Fukuda T, Sato T, Sekine K, Kato S, Isshiki M, Fujita T, Kobayashi M, Kawamura K, Masuda H, Kamiya A, Ando J (2006) Impaired flow-dependent control of vascular tone and remodeling in P2X4-deficient mice. Nat Med 12:133-137.
158. Yao L, Arolfo MP, Dohrman DP, Jiang Z, Fan P, Fuchs S, Janak PH, Gordon AS, Diamond I (2002) betagamma Dimers mediate synergy of dopamine D2 and adenosine A2 receptor-stimulated PKA signaling and regulate ethanol consumption. Cell 109:733-743.
159. Yao L, Fan P, Jiang Z, Mailliard WS, Gordon AS, Diamond I (2003) Addicting drugs utilize a synergistic molecular mechanism in common requiring adenosine and Gi-beta gamma dimers. Proc Natl Acad Sci U S A 100:14379-14384.
160. Yao L, McFarland K, Fan P, Jiang Z, Ueda T, Diamond I (2006) Adenosine A2a blockade prevents synergy between mu-opiate and cannabinoid CB1 receptors and eliminates heroin-seeking behavior in addicted rats. Proc Natl Acad Sci U S A 103:7877-7882.
161. Yao SY, Ng AM, Muzyka WR, Griffiths M, Cass CE, Baldwin SA, Young JD (1997) Molecular cloning and functional characterization of nitrobenzylthioinosine (NBMPR)-sensitive (es) and NBMPR-insensitive (ei) equilibrative nucleoside transporter proteins (rENT1 and rENT2) from rat tissues. J Biol Chem 72:28423-28430.